Literature DB >> 35559959

Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.

Vajeera Dorabawila1, Dina Hoefer1, Ursula E Bauer1, Mary T Bassett1, Emily Lutterloh1, Eli S Rosenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35559959      PMCID： PMC9107062          DOI： 10.1001/jama.2022.7319

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  5 in total

1.  Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.

Authors:  Ben Y Reis; Noam Barda; Michael Leshchinsky; Eldad Kepten; Miguel A Hernán; Marc Lipsitch; Noa Dagan; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-10-20       Impact factor: 91.245

2.  Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

Authors:  Emmanuel B Walter; Kawsar R Talaat; Charu Sabharwal; Alejandra Gurtman; Stephen Lockhart; Grant C Paulsen; Elizabeth D Barnett; Flor M Muñoz; Yvonne Maldonado; Barbara A Pahud; Joseph B Domachowske; Eric A F Simões; Uzma N Sarwar; Nicholas Kitchin; Luke Cunliffe; Pablo Rojo; Ernest Kuchar; Mika Rämet; Iona Munjal; John L Perez; Robert W Frenck; Eleni Lagkadinou; Kena A Swanson; Hua Ma; Xia Xu; Kenneth Koury; Susan Mather; Todd J Belanger; David Cooper; Özlem Türeci; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2021-11-09       Impact factor: 176.079

3.  Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.

Authors:  Ashley L Fowlkes; Sarang K Yoon; Karen Lutrick; Lisa Gwynn; Joy Burns; Lauren Grant; Andrew L Phillips; Katherine Ellingson; Maria V Ferraris; Lindsay B LeClair; Clare Mathenge; Young M Yoo; Matthew S Thiese; Lynn B Gerald; Natasha Schaefer Solle; Zuha Jeddy; Leah Odame-Bamfo; Josephine Mak; Kurt T Hegmann; Joe K Gerald; Jezahel S Ochoa; Mark Berry; Spencer Rose; Julie Mayo Lamberte; Purnima Madhivanan; Felipe A Pubillones; Ramona P Rai; Kayan Dunnigan; John T Jones; Karl Krupp; Laura J Edwards; Edward J Bedrick; Brian E Sokol; Ashley Lowe; Hilary McLeland-Wieser; Krystal S Jovel; Deanna E Fleary; Sana M Khan; Brandon Poe; James Hollister; Joanna Lopez; Patrick Rivers; Shawn Beitel; Harmony L Tyner; Allison L Naleway; Lauren E W Olsho; Alberto J Caban-Martinez; Jefferey L Burgess; Mark G Thompson; Manjusha Gaglani
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-03-18       Impact factor: 17.586

4.  Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

Authors:  Robert W Frenck; Nicola P Klein; Nicholas Kitchin; Alejandra Gurtman; Judith Absalon; Stephen Lockhart; John L Perez; Emmanuel B Walter; Shelly Senders; Ruth Bailey; Kena A Swanson; Hua Ma; Xia Xu; Kenneth Koury; Warren V Kalina; David Cooper; Timothy Jennings; Donald M Brandon; Stephen J Thomas; Özlem Türeci; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2021-05-27       Impact factor: 91.245

5.  Covid-19 Vaccine Effectiveness in New York State.

Authors:  Eli S Rosenberg; Vajeera Dorabawila; Delia Easton; Ursula E Bauer; Jessica Kumar; Rebecca Hoen; Dina Hoefer; Meng Wu; Emily Lutterloh; Mary Beth Conroy; Danielle Greene; Howard A Zucker
Journal:  N Engl J Med       Date:  2021-12-01       Impact factor: 91.245
  5 in total
  14 in total

1.  Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021.

Authors:  Hannes Winner; Janine Kimpel; Florian Krammer; Dorothee von Laer; Jörg Paetzold
Journal:  Euro Surveill       Date:  2022-09

2.  Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.

Authors:  Chiara Sacco; Martina Del Manso; Alberto Mateo-Urdiales; Maria Cristina Rota; Daniele Petrone; Flavia Riccardo; Antonino Bella; Andrea Siddu; Serena Battilomo; Valeria Proietti; Patrizia Popoli; Francesca Menniti Ippolito; Anna Teresa Palamara; Silvio Brusaferro; Giovanni Rezza; Patrizio Pezzotti; Massimo Fabiani
Journal:  Lancet       Date:  2022-07-01       Impact factor: 202.731

3.  COVID-19 vaccination for children aged 5-11 years.

Authors:  Shamez N Ladhani
Journal:  Lancet       Date:  2022-07-01       Impact factor: 202.731

4.  Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.

Authors:  Grace Li; Federica Cappuccini; Natalie G Marchevsky; Parvinder K Aley; Robert Aley; Rachel Anslow; Sagida Bibi; Katrina Cathie; Elizabeth Clutterbuck; Saul N Faust; Shuo Feng; Paul T Heath; Simon Kerridge; Alice Lelliott; Yama Mujadidi; Khuen Foong Ng; Sarah Rhead; Hannah Roberts; Hannah Robinson; Marion R Roderick; Nisha Singh; David Smith; Matthew D Snape; Rinn Song; Karly Tang; Andy Yao; Xinxue Liu; Teresa Lambe; Andrew J Pollard
Journal:  Lancet       Date:  2022-06-11       Impact factor: 202.731

5.  Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study.

Authors:  Soledad González; Santiago Olszevicki; Alejandra Gaiano; Ana Nina Varela Baino; Lorena Regairaz; Martín Salazar; Santiago Pesci; Lupe Marín; Verónica V González Martínez; Teresa Varela; Leticia Ceriani; Enio Garcia; Nicolás Kreplak; Alexia Navarro; Elisa Estenssoro; Franco Marsico
Journal:  Lancet Reg Health Am       Date:  2022-07-16

6.  The COVID-19 Vaccination Still Matters: Omicron Variant Is a Final Wake-Up Call for the Rich to Help the Poor.

Authors:  Piotr Rzymski; Agnieszka Szuster-Ciesielska
Journal:  Vaccines (Basel)       Date:  2022-07-03

7.  Cross-Sectional Survey on BNT162b2 mRNA COVID-19 Vaccine Serious Adverse Events in Children 5 to 11 Years of Age: A Monocentric Experience.

Authors:  Silvia Bloise; Alessia Marcellino; Beatrice Frasacco; Pietro Gizzone; Claudia Proietti Ciolli; Vanessa Martucci; Mariateresa Sanseviero; Emanuela Del Giudice; Flavia Ventriglia; Riccardo Lubrano
Journal:  Vaccines (Basel)       Date:  2022-07-30

8.  A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.

Authors:  Xiaofeng He; Jiao Su; Yu'nan Ma; Wenping Zhang; Shixing Tang
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

9.  SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany.

Authors:  A L Sorg; V Schönfeld; A Siedler; M Hufnagel; M Doenhardt; N Diffloth; R Berner; R V Kries; J Armann
Journal:  Infection       Date:  2022-09-01       Impact factor: 7.455

10.  Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study.

Authors:  Ofra Amir; Yair Goldberg; Micha Mandel; Yinon M Bar-On; Omri Bodenheimer; Laurence Freedman; Nachman Ash; Sharon Alroy-Preis; Amit Huppert; Ron Milo
Journal:  Lancet Infect Dis       Date:  2022-09-09       Impact factor: 71.421
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.